玉米污改善了2型糖尿病斑马鱼和GK大鼠的高血糖症
Haowei Liang1, Ruiqin Zhang1, Li Zhou2
1School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Journal of ethnopharmacology
|January 12, 2024
概括
在糖尿病模型中,Cornstigma (CS) 有效降低血糖,改善脂质代谢. 这项研究揭示了CS通过降低类固醇生物合成途径中的基因而起作用,为糖尿病治疗提供了新的见解.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 基因组学就是基因组学.
背景情况:
- 科恩斯蒂格玛 (CS) 源自Zea mays,在糖尿病管理中具有传统用途.
- 糖尿病是一种代谢障碍,其特点是高血糖和严重的慢性并发症.
- 在改善糖尿病中CS的精确机制仍然在很大程度上未被阐明.
研究的目的:
- 为了研究糖尿病的发病因子.
- 阐明CS在糖尿病模型中改善高血糖的机制.
主要方法:
- 在CS中使用UPLC/MS/MS的量化阿皮基宁和卢托林.
- 在GK大鼠和斑马鱼模型中评估葡萄糖和脂质代谢指标.
- 在斑马鱼上进行了转录组测序,以确定差异表达的基因和途径.
- 使用PCR验证了关键基因表达变化.
主要成果:
- 在GC大鼠和糖尿病斑马鱼中,CS表现出显著的低血糖效应.
- 在老鼠中,CS治疗部分使葡萄糖和脂质代谢指标正常化.
- 转录组分析显示,CS治疗与类固醇生物合成途径之间存在相关性.
- 在类固醇生物合成途径中,CS降低了基因 (fdft1,lss,cyp51) 的表达.
结论:
- 康斯蒂格玛有效改善血糖水平,调节葡萄糖和脂质代谢.
- CS通过抑制类固醇生物合成途径中的基因表达来发挥其低血糖作用.
- 这项研究为糖尿病治疗的CS提供了宝贵的见解,并提出了临床药物选择的新策略.
更多相关视频
10:03A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.8K
13:35Acute and Chronic Models of Hyperglycemia in Zebrafish: A Method to Assess the Impact of Hyperglycemia on Neurogenesis and the Biodistribution of Radiolabeled Molecules
Published on: June 26, 2017
13.4K
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
204
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204
Dipeptidyl Peptidase 4 Inhibitors
188
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
188
